Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,891,742
  • Shares Outstanding, K 31,047
  • Annual Sales, $ 311,330 K
  • Annual Income, $ -9,020 K
  • 60-Month Beta 1.94
  • Price/Sales 12.58
  • Price/Cash Flow N/A
  • Price/Book 5.48
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.34
  • Most Recent Earnings -0.02 on 05/11/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.60
  • Number of Estimates 10
  • High Estimate -0.24
  • Low Estimate -0.84
  • Prior Year -0.78
  • Growth Rate Est. (year over year) +23.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
116.08 +7.99%
on 06/15/20
133.63 -6.19%
on 06/19/20
-1.92 (-1.51%)
since 06/02/20
3-Month
80.70 +55.34%
on 04/03/20
134.35 -6.70%
on 05/26/20
+40.83 (+48.31%)
since 04/02/20
52-Week
67.98 +84.39%
on 03/17/20
180.75 -30.65%
on 07/10/19
-45.49 (-26.63%)
since 07/02/19

Most Recent Stories

More News
Recent Analysis on Medicinal Cannabis Market (impact of COVID-19) Growth with Top Companies details like: BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation

APHA : 4.30 (-1.38%)
ACB.TO : 16.35 (-1.09%)
GWPH : 125.35 (-0.67%)
INSY : 0.29 (unch)
HEMP : 0.0058 (+1.75%)
Zynerba's Zygel Fails in Phase III Fragile X Syndrome Study

Zynerba's (ZYNE) shares plunge 48.5% following the study data readout, which demonstrated failure to achieve statistical significance in primary endpoint.

ALDX : 4.17 (unch)
GWPH : 125.35 (-0.67%)
ZYNE : 3.50 (-5.66%)
ATXI : 10.47 (-0.29%)
Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment

Zogenix (ZGNX) gets FDA nod for Fintepla oral solution, CIV for the treatment of seizures associated with Dravet Syndrome in patients 2 years of age or older.

ZGNX : 29.19 (+0.41%)
MEIP : 3.49 (-18.27%)
GWPH : 125.35 (-0.67%)
AMRX : 4.52 (-2.59%)
Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba

Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba

GWPH : 125.35 (-0.67%)
ZYNE : 3.50 (-5.66%)
CGC : 16.45 (-0.12%)
ACB : 12.27 (unch)
HEXO : 0.7230 (-2.30%)
Is This a Buying Opportunity in the Marijuana Stocks?

The marijuana stocks plunged during the coronavirus sell-off. Should investors be taking a second look?

GWPH : 125.35 (-0.67%)
ZYNE : 3.50 (-5.66%)
CGC : 16.45 (-0.12%)
ACB : 12.27 (unch)
HEXO : 0.7230 (-2.30%)
GW Pharmaceuticals announces that EPIDYOLEX(R) (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug

GW's cannabis-based medicine rescheduled following approval by the European Medicines Agency (EMA) and an independent assessment by the Advisory Council on the Misuse of Drugs (ACMD)

GWPH : 125.35 (-0.67%)
Cannabis Extraction Market Latest Research, Growing Demand and Business Outlook 2020 to 2026

The Latest report about the market provides a detailed evaluation of the business vertical in question, alongside a brief overview of the industry segments. An exceptionally workable estimation of the...

ACB.TO : 16.35 (-1.09%)
GWPH : 125.35 (-0.67%)
MRRCF : 0.0050 (unch)
Marijuana Stocks Weekly Recap

This week in the Marijuana Weekly Recap, we report on news released from Aurora Cannabis (ACB) and HEXO (HEXO), and update readers on GW Pharmaceuticals (GWPH)   After a devastating plunge in the...

ACB : 12.27 (unch)
MJ : 12.92 (-0.46%)
HEXO : 0.7230 (-2.30%)
GWPH : 125.35 (-0.67%)
Thailand Medical Cannabis Market Research Report 2019, Industry Trends, Share, Size, Demand and Future Scope

The Thailand medical cannabis market has witnessed stable growth over the past few years. This can be attributed to the various healing properties of cannabis which range from calming the mind and body...

APHA : 4.30 (-1.38%)
ACB.TO : 16.35 (-1.09%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MEDFF : 18.8100 (-0.37%)
CGC : 16.45 (-0.12%)
GWPH : 125.35 (-0.67%)
Is it Time to Buy Cannabis Stocks & ETFs?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

GWPH : 125.35 (-0.67%)
IBUY : 73.35 (+1.58%)
IIPR : 92.79 (-1.03%)
CGC : 16.45 (-0.12%)
CRON : 6.17 (+0.98%)
CNBS : 11.14 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade GWPH with:

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 129.30
1st Resistance Point 127.32
Last Price 125.35
1st Support Level 123.82
2nd Support Level 122.29

See More

52-Week High 180.75
Fibonacci 61.8% 137.67
Last Price 125.35
Fibonacci 50% 124.37
Fibonacci 38.2% 111.06
52-Week Low 67.98

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar